HF diagnosis heightens depression, suicide risk in men, women

Loading

Both men and women with HF faced higher risks for depression and death by suicide in the first 3 months after their diagnosis, researchers reported in JACC: Heart Failure.

“The large burden of disease associated with HF may potentially cause psychosocial distress that worsens suffering, quality of life and long-term health outcomes,” Casey Crump, MD, PhD, vice chair for research in the department of family medicine and community health at Mount Sinai, and colleagues wrote.  Read more in Healio.

Loading

Post-Transplant Diabetes Can Be Predicted in Kidney Recipients

Loading

Researchers published the study covered in this summary on Research Square and it has not yet been peer reviewed.

Key Takeaways

  • A retrospective, case-control study of kidney transplant recipients in China identified that a combination of the following parameters can predict post-transplant diabetes mellitus (PTDM) diagnosed after 45 days:
    • Family history of diabetes mellitus.
    • Standard deviation of fasting plasma glucose when values are fluctuating (day 3 to day 11 post-transplant).
    • Maximum fasting plasma glucose when values have stabilized (week 3 to week 6 post-transplant).
      Read the full story in MedScape.
Loading

In Memoriam: Jim Gleason, Transplant Patient Advocate

Loading

CareDx commemorates the life of James “Jim” Gleason, a selfless leader, patient advocate, heart transplant recipient and longtime President of the Transplant Recipients International Organization (TRIO), who died on August 26, 2022, after battling incurable pancreatic cancer. Jim spent the last few days of his life the same way he lived his life, by being a friend and patient advocate, while also working tirelessly to ensure that his organization’s important work for the transplant community would remain unabated. Meanwhile, he remained accessible to his inner circle of family, friends, industry partners, patients, and donor families. Read more at CareDx.com.

Loading

Risks for heart disease, disability, death higher with younger age at diabetes diagnosis

Loading

The risk for heart disease, stroke, disability and mortality among adults with diabetes is higher for those diagnosed at age 50 to 59 years than those diagnosed at age 70 years or older, according to study findings.

In an analysis of data from adults aged 50 years and older participating in the Health and Retirement Study in the U.S., adults who reported they were diagnosed with diabetes at age 50 to 59 years had an increased risk for heart disease, stroke, disability, cognitive impairment and mortality compared with matched controls without diabetes, whereas adults diagnosed at age 70 years or older had a higher risk for only mortality compared with controls. Data did not distinguish between type 1 and type 2 diabetes.
Read the full story in Healio.

Loading

Speed Bumps Are Inevitable on the Post-transplant Journey

Loading

Columnist Sam Kirton is quick to respond to some concerning symptoms

While working on today’s column, I considered writing about my birthday on Oct. 4. Then, a topic came to me quite unexpectedly.

On Monday, Sept. 26, I had to go to the hospital. Since the pandemic began, I’ve been careful to avoid large crowds in enclosed spaces and to always wear a mask indoors. So I was quite surprised to learn I had pneumonia — a significant complication for a post-lung transplant patient. Read more in Pulmonary Fibrosis News.

Loading

The Search Is On for Another Xeno Heart Transplant Recipient

Loading

— Transplant surgeons discuss testing the concept in more humans


share to facebook
share to twittershare to linkedinemail article

NATIONAL HARBOR, Md. — Playing by the strict rules of the FDA, xenotransplant researchers are itching to apply the lessons learned from this year’s historic case of cardiac surgery in their quest to move the transplant field forward amid a strained supply of donor organs.

In the landmark case, the first person to undergo a pig heart xenotransplant, David Bennett, age 57, had been denied a traditional human heart transplant from several programs before he ultimately agreed to the experimental surgery. The FDA green-lit the xenotransplant, and Bennett was kept alive for 60 days before succumbing to graft failure and sudden diastolic failure without evidence of traditional allograft rejection.
Read the full story in MedPage Today.

Loading

Young Man Becomes First in World to Be Cured of FSGS With New Treatment

Loading

Combined stem cell transplant and kidney transplant prove a winning combination against autoimmune FSGS

Imagine spending a good share of your childhood hooked up to a machine. While your friends are traveling on a bus to a school game or hanging out at the mall, you are at home or at a dialysis center tethered by cords, every day for at least three hours. A lot of kids would give up trying to keep up with life. Not 21-year-old Traejen Kingston. 
Read the full story from Stanford Children’s Health.

Loading

FDA: Evusheld may lack efficacy against upcoming COVID-19 subvariants

Loading

Evusheld demonstrates reduced protection against the omicron subvariant BA.4.6, resulting in an increased risk for infection in those exposed to that COVID-19 strain, according to an updated FDA fact sheet.

In the revised fact sheet, the FDA warned that providers should be aware of an increased risk for developing COVID-19 when exposed to certain COVID-19 variants that are not neutralized by tixagevimab packaged with cilgavimab (Evusheld, AstraZeneca).
Read the full story in Healio.

Loading

Dialysis providers assess damage from Hurricane Ian

Loading

Dialysis providers deployed disaster response teams this past week along the coast of Florida to assess the damage from Hurricane Ian while watching its path into Georgia and the Carolinas.

“Hurricane Ian impacted multiple U.S. Renal Care dialysis clinics along the west coast of Florida from Tampa to Naples, leaving many clinics without power, water, internet or phone access,” Mary Dittrich, MD, chief medical officer of U.S. Renal Care, told Healio. 
Read the full story from Healio.

Loading